• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail
-

Section Contents Menu

Enforcement Actions

-
 

2000 Warning Letters

-

Recently Posted | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |

Tobacco Retailer Warning Letters

 

-

Warning Letters for 2000

Recently Posted | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996

 

* Not issued: A close-out letter may issue when, based on FDA’s evaluation, the firm has taken corrective action to address the violations contained in the Warning Letter. This procedure applies to Warning Letters issued on or after September 1, 2009.

* N/A: Not applicable, the Warning Letter was issued prior to September 1, 2009.

Read more about warning and close-out letters

 
Letter Issue Date Company Name Issuing Office Subject Close Out Date
December 20, 2000 Alexander Community Hospital Atlanta District Office Mammography Standards N/A *
December 20, 2000 Banco de Sangre Humacao Inc. San Juan District Office Good Manufacting Practices for Blood and Components N/A *
December 20, 2000 Elcat Company New Orleans District Office Methamphetamine Hydrochloride/Active Pharmaceutcal Ingredients/Adulterated N/A *
December 19, 2000 U.S. Food Service Inc. New England District Office Seafood Processing Regulations/HACCP N/A *
December 19, 2000 Kodiak Smoking and Processing Seattle District Office Seafood Processing Regulations/HACCP N/A *
December 19, 2000 Belford Seafood Co-Op New Jersey District Office Seafood Processing Regulations/HACCP N/A *
December 19, 2000 E.A. Conway Medical Center New Orleans District Office Mammography Standards N/A *
December 18, 2000 Xinjiang Pharmaceutical Factory Center for Drug Evaluation and Research Active Pharmaceutical Ingredient Mfr Facility/Adulterated/Manufacturing Processing Packaging etc. N/A *
December 18, 2000 Blue Light Inc. New York District Office New Drug/Misbranded/Adulterated N/A *
December 18, 2000 ADI Corporation Center for Devices and Radiological Health Television/Computer Monitor Factories/Automatic Detention N/A *
December 18, 2000 Marukai Corporation San Francisco District Office Seafood Processing Regulations/HACCP N/A *
December 18, 2000 Coram Healthcare New Orleans District Office Liquid Medical Oxygen/Adulterated N/A *
December 16, 2000 Missa Bay Inc. New Jersey District Office Seafood Processing Regulations/HACCP N/A *
December 15, 2000 Ultralite Enterprises Inc. Atlanta District Office Quality System Regulation/Phototherapy Units/Adulterated N/A *
December 15, 2000 Upcountry Fishery Inc. San Francisco District Office Seafood Processing Regulations/HACCP N/A *
December 15, 2000 Ultralite Enterprises Inc. Atlanta District Office Quality System Regulation/Phototherapy Units/Misbranded/MDR Reporting/Adulterated N/A *
December 15, 2000 C & J Seafood Inc. New Orleans District Office Seafood Processing Regulations/HACCP N/A *
December 15, 2000 Murex Diagnostics Inc. Center for Biologics Evaluation and Research Quality System Regulation N/A *
December 14, 2000 Tianjin Xin Xin Pharmaceutical Corporation Center for Drug Evaluation and Research Active Pharmaceutical Ingredient/Adulterated/FMP's Manufacturing Processing Packing etc. N/A *
December 14, 2000 Genentech Inc. Center for Biologics Evaluation and Research Good Manufacturing Practices for Finished Pharmaceuticals/Biological Products General Provisions N/A *



-
 

Contact FDA

ICECI Warning Letters

Division of Freedom of Information (HFI-35)

Food and Drug Administration

5600 Fishers Lane

Rockville, MD 20857
-
-
-
-